Pharmacological Preparation of the Cervix for Hysteroscopy

• Status: Completed
• Trial end date: 2023-01-31
• Target enrollment: 0
• Participant gender: Female

Summary

Pain accompanying office hysteroscopy is the most common reason for its discontinuation. Urogenital atrophy may cause technical difficulties in passage through the cervical canal, further increasing the pain. The aim was to evaluate the effectiveness of vaginal estradiol and hyaluronic acid to facilitate diagnostic hysteroscopy in peri- and postmenopausal women.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Jagiellonian University
• Treatments: Estradiol; Hyaluronic Acid

Criteria

Inclusion Criteria:

• age 45-90 years

• uterine cavity focal lesion, abnormal uterine bleeding

Exclusion Criteria:

• drug allergy

• no consent to the procedure or participation in the study